While MAPK/ERK activation has been seen across all astrocytoma types, including sporadic and NF1-associated astrocytomas, MAPK/ERK activation in NF1-associated astrocytomas is independent of BRAF alteration [104]. This evidence concerns the gene NF1 and astrocytoma (excluding glioblastoma).